Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mildronate for stable angina pectoris (exercise tolerance)
2007-005179-32Phase 2Completed
- Sponsor
- Grindeks
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronary arteriosclerosis comparing Mildronate + standard therapy with Placebo + standard therapy (2 arms). Primary endpoint: Change in exercise time on bicycle ergometry at 12 weeks. Started Jun 2008; status: completed.
02
Drugs
meldonium
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2007-005179-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005179-32.